DABRAFENIB FOR RESISTANT BRAF MUTATED MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS

被引：0
|
作者：
Hays, Julia Allyson [1 ,2 ]
机构：
[1] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[2] Univ Missouri, Kansas City, MO 64110 USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [21] DEVELOPMENT OF RHEUMATOID ARTHRITIS DURING THE LONG TIME COURSE OF MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Tiganova, Olga
    Bronin, Gleb
    Kondratchik, Konstantin
    Kovaliova, Olga
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 691 - 691
  • [22] Vaccine Associated Soft Tissue Infiltrate Can Predispose Multi-System Langerhans Cell Histiocytosis
    Bronin, Gleb
    Kislyakov, Alexey
    Kondratchik, Konstantin
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S2 - S2
  • [23] Biomodulatory therapy induces long-lasting remissions in chemorefractory multi-system Langerhans cell histiocytosis
    Harrer, D. C.
    Jakob, M.
    Vogelhuber, M.
    Lueke, F.
    Rehe, K.
    Corbacioglu, S.
    Herr, W.
    Reichle, A.
    Heudobler, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 183 - 183
  • [24] MAPPING NON-BRAFV600E HEMATOPOIETIC CLONES IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Milne, Paul
    Abhyankar, Harshal
    Scull, Brooks
    Singh, Preeti
    Chakraborty, Rikhia
    Collin, Matthew
    Allen, Carl E.
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [25] Bortezomib alone or in combinination with Doxil is active in adult refractory multi-system Langerhans cell histiocytosis (LCH)
    Haddad, Philip A.
    BLOOD, 2007, 110 (11) : 27B - 27B
  • [26] Activity of Bortezomib alone or in combination with Doxil in adult refractory multi-system Langerhans cell histiocytosis (LCH)
    Haddad, Philip A.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 869 - 869
  • [27] Adult Langerhans cell histiocytosis with multi-system bone, skin, lung and liver involvement: A case report
    Lei, Qiucheng
    Hong, Xitao
    Yuan, Jianxiang
    Zheng, Huazhen
    Deng, Feiwen
    BIOMEDICAL REPORTS, 2024, 21 (05)
  • [28] Successful Vemurafenib Re-Challenge at Disease Reactivation in Refractory Multi-System Langerhans Cell Histiocytosis
    Soh, S. Y.
    Htet, L. L.
    Lian, D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S403 - S404
  • [29] Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis
    Rao Nanduri, Vasanta
    Pritchard, Jon
    Levitt, Gill
    Glaser, Adam W.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) : 2563 - 2569
  • [30] MAPPING THE BRAFV600E HEMATOPOIETIC CLONE OF ADULT MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Milne, Paul
    Collin, Matthew
    Bigley, Venetia
    Bacon, Chris M.
    McGovern, Naomi
    Windebank, Kevin
    Allen, Carl
    McClain, Kenneth
    Haniffa, Muzlifah
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S12 - S12
12345